Literature DB >> 34704589

First Malian series of surgery for rheumatic valve disease: opening of the centre, clinical features and peri-operative realities.

Mahamadoun Coulibaly1, Siriman A Koita2, Modibo Doumbia3, Binta Diallo4, Salia I Traore4, Baba I Diarra3, Brehima Coulibaly5, Sanoussy Daffe6, Asmaou Maiga7, Mamadou Toure7, Rakiswendé A Zongo4, Gaoussou Fofana8, Seydina A Beye9, Boubacar Diallo10, Mamadou B Diarra7, Djibo M Diango11, Youssouf Coulibaly9.   

Abstract

INTRODUCTION: Over the past two decades, the incidence of acute rheumatic fever (ARF) and chronic rheumatic heart disease (RHD) have dramatically declined in wealthier regions of the world as a result of preventative programmes, improved living standards and access to cardiac surgery. Nevertheless, ARF and RHD are still public health problems in less-developed regions of the world such as Oceania, south Asia and sub-Saharan Africa. AIM: We report on clinical, therapeutic and prognostic aspects as well as the difficulties encountered during this first series of surgery for rheumatic valve disease in Mali.
METHODS: This was a prospective, descriptive study conducted at the Andre Festoc Cardiac Surgery Centre from September 2018 to August 2019.
RESULTS: The frequency of patients having been operated on for rheumatic valve disease was 44.73% (68 patients). The mean age of the patients was 18 ± 10 years with extremes of five and 60 years. The gender ratio was 0.7. The delay to treatment was between one and three years for 39.7% of the patients. The main diagnoses found were: mitral regurgitation in 50% of patients, mitral stenosis in 16.2% and aortic regurgitation in 10.3%. Pulmonary artery systolic pressure was 35-50 mmHg in 19.1% of patients and more than 50 mmHg in 25%. The median cardiopulmonary bypass time was 132 minutes (60-276) and median extubation time was three hours (0-96). The main complications were cardiac, renal, neurological, respiratory, gastrointestinal and infectious. In the immediate postoperative period, we recorded three deaths, which is a mortality rate of 4.4%.
CONCLUSIONS: Humanitarian efforts have led non-governmental organisations (NGOs) to launch surgical programmes in low-and middle-income countries in an attempt to fill the gap in these fragile healthcare systems. Cardiac surgery requires much expertise from the medical staff, as well as many material and financial resources. Empowerment of the local team is a challenge that is being realised since taking these essential steps of companionship with the NGO la Chaine de l'Espoir.

Entities:  

Keywords:  cardiac surgery; la Chaine de l'Espoir; pulmonary hypertension; rheumatic heart disease

Mesh:

Year:  2021        PMID: 34704589      PMCID: PMC9364477          DOI: 10.5830/CVJA-2021-042

Source DB:  PubMed          Journal:  Cardiovasc J Afr        ISSN: 1015-9657            Impact factor:   0.802


  20 in total

1.  Risk factors of postoperative atrial fibrillation after cardiac surgery.

Authors:  Johann Auer; Thomas Weber; Robert Berent; Choi-Keung Ng; Gudrun Lamm; Bernd Eber
Journal:  J Card Surg       Date:  2005 Sep-Oct       Impact factor: 1.620

2.  Global cardiac surgery: Access to cardiac surgical care around the world.

Authors:  Dominique Vervoort; Bart Meuris; Bart Meyns; Peter Verbrugghe
Journal:  J Thorac Cardiovasc Surg       Date:  2019-04-26       Impact factor: 5.209

Review 3.  Pulmonary hypertension in valvular disease: a comprehensive review on pathophysiology to therapy from the HAVEC Group.

Authors:  Julien Magne; Philippe Pibarot; Partho P Sengupta; Erwan Donal; Raphael Rosenhek; Patrizio Lancellotti
Journal:  JACC Cardiovasc Imaging       Date:  2015-01

4.  [Pediatric heart surgery in developing countries. Twenty years experience of La Chaine de L'espoir (Chain of Hope)].

Authors:  Alain Deloche; G Babatasi; Olivier Baron; Daniel Roux; Sylvain Chauvaud; Daniel Sidi; Pascal Vouhé
Journal:  Bull Acad Natl Med       Date:  2011-02       Impact factor: 0.144

Review 5.  Inhaled nitric oxide for the postoperative management of pulmonary hypertension in infants and children with congenital heart disease.

Authors:  Matthew Bizzarro; Ian Gross; Fabiano T Barbosa
Journal:  Cochrane Database Syst Rev       Date:  2014-07-03

6.  Economic consequences of rheumatic heart disease: A scoping review.

Authors:  Chinonso C Opara; Negeen Aghassibake; David A Watkins
Journal:  Int J Cardiol       Date:  2020-09-10       Impact factor: 4.164

7.  Cardiac surgery capacity in sub-saharan Africa: quo vadis?

Authors:  Charles Yankah; Francis Fynn-Thompson; Manuel Antunes; Frank Edwin; Christine Yuko-Jowi; Shanthi Mendis; Habib Thameur; Andreas Urban; Ralph Bolman
Journal:  Thorac Cardiovasc Surg       Date:  2014-06-23       Impact factor: 1.827

Review 8.  Rheumatic heart disease in Africa: is there a role for genetic studies?

Authors:  Ana Olga Mocumbi
Journal:  Cardiovasc J Afr       Date:  2015 Mar-Apr       Impact factor: 1.167

9.  Morbidity After cardiac surgery under cardiopulmonary bypass and associated factors: A retrospective observational study.

Authors:  Chitralekha Patra; Prabhushankar Chamaiah Gatti; Ansuman Panigrahi
Journal:  Indian Heart J       Date:  2019-08-06

10.  Predictors of short-term mortality after rheumatic heart valve surgery: A single-center retrospective study.

Authors:  Khalid S Ibrahim; Khalid A Kheirallah; Fadia A Mayyas; Nizar R Alwaqfi; Murtada H Alawami; Qusai M Aljarrah
Journal:  Ann Med Surg (Lond)       Date:  2021-01-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.